20
Views
24
CrossRef citations to date
0
Altmetric
Research Article

THE ROLE OF ENDOTHELIAL CELL DYSFUNCTION IN THE CARDIOVASCULAR MORTALITY OF RA

, , , &
Pages 1-17 | Published online: 03 Aug 2009

  • T. Pincus, Long term outcomes in rheumatoid arthritis. Br. J. Rheumatol., 34(suppl. 2): 59-73, 1995.
  • S.E. Gabriel, S.C. Crowson, W.M. O'Fallon, Mortality in rheumatoid arthritis: Have we made an impact in 4 decades?, J. Rheumatol., 26: 2529-2533, 1999.
  • S. Manzi and M.C. Wasko, Inflammation-mediated rheumatic diseases and atherosclerosis. Ann. Rheum. Dis., 59: 321-325, 2000.
  • H. Wallberg-Johnson, H. Ohman M. -L. Johansson and S. Rantappa Dahlqvist, Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. J. Rheumatol., 26: 2562-2570, 1999.
  • R.R. Monson and A.P. Hall, Mortality amongst arthritics. J. Chron. Dis., 29: 459-467, 1976.
  • D.P. M. Symmons, P. Prior, D.L. Scott, R. Brown and C.F. Hawkins, Factors influencing mortality in rheumatoid arthritis. J. Chron. Dis., 39: 137-145, 1986.
  • F. Wolfe, D.M. Mitchel and J.T. Sibley, The mortality of rheumatoid arthritis. Arthritis Rheum., 37: 481-484, 1994.
  • O. Mutru, M. Laasko, H. Isomaki and K. Koota, Ten year mortality and cause of death in patients with rheumatoid arthritis. BMJ, 290: 1811-1813, 1984.
  • A.H. Bagenstoss and E.F. Rosenberg, Visceral lesions associated with chronic infectious (rheumatoid) arthritis. Arch. Path, 199: 855-857, 1943.
  • R.J. Moots and P.A. Bacon, Extra-articular rheumatoid arthritis and allied conditions. A textbook of rheumatology. W.J. Koopman, Ed. Williams & Wilkins: USA, 1071-1088, 1997.
  • G.D. Kitas, M.J. Banks and P.A. Bacon, Cardiac involvement in rheumatoid disease. Clin. Med. JRCPL, 1: 18-21, 2001.
  • E. Sigurdsson, G. Thorgeisson, H. Sigvaldason and N. Sigfusson, Prevalence of coronary heart disease in Icelandic men 1968-1986. The Reykjavik study. Eur. Heart J., 14(5): 584-591, 1993.
  • S. Gabriel, C. Crowson, W.M. O'Fallon, Heart disease in rheumatoid arthritis. Arthritis Rheum, 9(suppl. 1): S132, 1998.
  • P. Allebeck, A. Ahlbom and E. Alender, Increased mortality among patients with rheumatoid arthritis, but where RA does not appear on the death certificate. Scand. J. Rheumatol., 10: 301-306, 1998.
  • M.J. Banks and G.D. Kites, Patients' disability in RA may influence doctors' perception of suitability for risk assessment of CHD. BMJ, 319: 1266, 1999.
  • M.J. Banks, J. Flint, P.A. Bacon and G.D. Kitas, Rheumatoid arthritis is an independent risk factor for ischaemic heart disease. Arthritis Rheum., 1909: S358, 2000.
  • J. -P. Raynauld, Cardiovascular mortality in rheumatoid arthritis: How harmful are corticosteroids. J. Rheumatol., 24: 415-416, 1997.
  • R.B. M. Landewe, B.E. van den Borne, F.C. Breedveld and B.A. Dijkmans, Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet, 355(9215): 1616, 2000.
  • N.J. Goodson, N.J. Wiles, M. Lund et al., Increased mortality in seropositive patients during the early years of inflammatory polyarthritis. Rheumatology, 40: 202, 2001.
  • Y. Kumeda, M. Inaba, Y. Kurioka et al., Progression of atherosclerosis in common cartoid artery (CCA) of patients with Rheumatoid Arthritis (RA) - measurement of intimamedia thickness (IMT) by ultrasonography. Arthritis Rheum., 1911: S385, 2000.
  • R.D. Situnayake and G.D. Kitas, Dyslipidamia in rheumatoid arthritis. Ann. Rheum. Dis., 56: 341-342, 1997.
  • P.A. Bacon and G.D. Kitas, The significance of vascular inflammation in rheumatoid arthritis. Ann. Rheum. Dis., 14: 621-623, 1994.
  • P.M. Ridker, M. Cushman, M.J. Stampher et al., Inflammation, aspirin and the risk of cardiovascular disease in apparently health men. N. Eng. J. Med. 336(14): 973-979, 1997.
  • R. Ross, Atherosterosis - an inflammatory disease. N. Eng. J. Med., 340: 115-126, 1999.
  • S.Z. Gao, J.S. Schroeder, S. Hunt and E.B. Stinson, Retransplantation for severe accelerated coronary disease in heart transplantation recipients. Am. J. Cardiol., 62: 867, 1988.
  • J. Aranda Jr. and J. Hill, Cardiac transplant vasculopathy. Chest. 118(6): 1792-1800,2000.
  • D.G. I. Scott, P.A. Bacon and C.R. Tribe, Systemic rheumatoid vasculitis: A clinical and laboratory study of 50 cases. Medicine (Baltimore), 60(4): 288-297, 1981.
  • K. Raza, T. Thambyrajah, J. Townend et al., Suppression of inflammation in primary systemic vasculitis restores endothelial function: Lessons for atherosclerosis disease? Circulation, 102: 1470-1472, 2000.
  • A.R. Exley, P.A. Bacon, R. Luqmani et al., Development and initial validation of the vasculitis damage index (VDI) for the standardised clinical assessment of damage in the systemic vasculitides. Arthritis Rheum., 40(2): 371-380, 1997.
  • A.R. Exley, D. Carruthers, R.A. Luqmani et al., Damage occurs early in systemic vasculitis and is an index of outcome. QJM, 90: 391-399, 1997.
  • J.C. Jennette and R.J. FaIk, Small-vessel vasculitis. New Eng. J. Med., 337: 1512-1523, 1995.
  • A.D. Filer, K. Raza, J. Thambyrajah et al., Endothelial dysfunction and primary systemic vasculitis (PSV): reversibility and impairment by disease group. Arthritis and Rheum., 340: S123, 2000.
  • A.D. Filer, J.M. Gardner-Medwin, K. Raza et al., Primary systemic vasculitis and endothelial: Analysis by disease subgroup and vascular bed. Rheumatology, 9: 24, 2001.
  • J. Thambyrajah, M.J. Landray, F.J. McGlynn et al., Abnormalities of endothelial function in patients with predialysis renal failure. Heart, 83: 205-209, 2000.
  • A.D. Filer, J.M. Gardner-Medwin, J. Thambyrajah et al., Endothelial dysfunction is a feature of ANCA associated and non-ANCA associated systemic vasculitis and can be demonstrated in two vascular beds. 2001. Paper submitted.
  • R.A. Luqmani, P.A. Bacon, M. Beaman et al., Classical versus non-renal wegeners granulomatosis. QJM, 87: 161-167 1994.
  • L. Harper and C.O. S. Savage, Pathogenesis of ANCA-associated systemic vasculitis. J. Pathol., 190: 349-359, 2000.
  • J.W. Cohen Tervaert, M.G. Huitema, R.J. Hene et al., Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet, 336: 709-711, 1990.
  • A. Wiik, What you should know about PR3-ANCA. An introduction. Arthritis Res., 4: 252-254, 2000.
  • K. Bhagat and P. Vallance, Inflammatory cytokines impair endothelium-dependent dilation in human veins in vivo. Circulation, 6: 3042-3047, 1997.
  • A.D. Hingorani, J. Cross and R.K. Kharbanda, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation, 102: 994-999, 2000.
  • M. Felman, F.M. Brennan and R.N. Maini, Role of cytokines in rheumatoid arthritis. Ann. Rev. Immunol., 14: 397-340, 1996.
  • P. Vallance, J. Collier and K. Bhagat, Infection, inflammation and infarction: Does acute endothelial dysfunction provide a link. Lancet, 349: 1391-1392, 1997.
  • A.J. Lusis, Atherosclerosis. Nature, 407: 2233-2241, 2000.
  • F. Liuzzo, L.M. Biasucci, J.R. Gallimore et al., The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N. Engl. J. Med., 331(7): 417-424, 1994.
  • F. Haverkate, S.G. Thompson, S.D. Pyke, J.R. Gallimore and M.B. Pepys, Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities. Angina pectoris study group. The Lancet, 349: 462-466, 1997.
  • P.M. Ridker, N. Rifai, M.A. Pfeffer, F. Sacks and E. Braunwald, Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation, 100: 230-235, 1999.
  • R. Ross and J.A. Glomset, The pathogenesis of atherosclerosis I. N. Eng. J. Med., 295: 369-377, 1976.
  • D.S. Celermajer, K.E. Sorensen, V.M. Gooch et al., Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340: 1111-1115, 1992.
  • K.K. Griendling and R.W. Alexander, Oxidative stress and cardiovascular disease. Circulation, 96: 3264-3265, 1997.
  • S. Manzi, E.H. Meilahn, J.E. Rairie et al., Age specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study. Am. J. Epidemiol., 145: 408-415.
  • S. Manzi, F. Selzer, K. Sutton-Tyrrell et al., Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum., 42: 51-60, 1999.
  • M. K. Piper, S. Heaton, J. Gardner-Medwin, J. Townend, P. A. Bacon and C. Gordon, A study of endothelial function in systemic lupus erythematosus (SLE). Rheumatology, 319: 113, 2001.
  • K. Bhagat, R. Moss, J. Collier and P. Vallance, Endothelial stunning following a brief exposure to endotoxin; a mechanism to link infection to infarction? Cardiovasc. Res., 32: 822-829, 1996.
  • P. Wang, Z.E. Ba and I.H. Chaudry, Administration of tumor necrosis factor-alpha in vivo depresses endothelium dependent relaxation. Am. J. Physiol., 266: H2535-H2541, 1994.
  • A.T. Stopeck, A.C. Nicholson, F.P. Mancini and O.P. Hajjar, Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J. Biol. Chem., 268: 17489-17494, 1993.
  • D.P. Hajjar and M.E. Haberland, Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J. Biol. Chem., 272: 22975-22978, 1997.
  • M.L. Westedt, C.J. Meijer, B.J. Vermeer and A. Cats, de of immunopathological abnormalities in normal skin. J. Rheumatol., 1: 448-453, 1984.
  • R.A. Watts, D.M. Carruthers, D.P. M. Symmons and D.G. I. Scott, The incidence of rheumatoid vasculitis in the Norwich Health Authority. BJR, 33: 832-834, 1994.
  • normal skin in Rheumatoid Arthritis. BJR, 24: 340-345, 1985.
  • L. Sokoloff, S.L. Wilens and J.J. Bunim, Arteritis of striated muscle in rheumatoid arthritis. Am. J. Pathol., 27: 157-173, 1951.
  • R. Flipo, A. Janin, E. Hachulla et al., Labial salivary gland biopsy assessment in rheumatoid vasculitis. Ann. Rheum. Dis., 54: 648-652, 1994.
  • E. Hurt-Camejo, S. Paredes, M. Lluis et al., Rheumatoid arthritis patients have elevated levels of small low-density lipoprotein with high affinity for arterial matrix components; possible contribution of phospholipase A2 to this atherogenic profile. Arthritis Rheum., 2001. In Press.
  • S. Rantapaa-Dahlqvist, S. Wallberg-Jonsson and G. Dahlen, Lipoprotein(a), lipids and lipoproteins in patients with rheumatoid arthritis. Ann. Rheum. Dis., 50: 366-368, 1991.
  • G. Liuzzo, S.L. Kopecky, R.L. Frye et al., Perturbation of the T cell repertoire in patients with unstable angina. Circulation, 100: 2135-2143, 1999.
  • K.J. Warrington, S. Takemura, J.J. Goronzy and C.M. Weyand, CD4+ CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum., 44: 13-20, 2001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.